Background Cytomegalovirus (CMV)‐negative recipients of a graft from a CMV‐positive
donor (D+/R−) are at high risk of CMV disease. Current preventive strategies include …

Objectives Universal prophylaxis and preemptive therapy are used to prevent
cytomegalovirus (CMV) disease post-transplantation. Data regarding which strategy is …

Cytomegalovirus (CMV) infection is an opportunistic infection frequently found after solid
organ transplantation, and it contributes significantly to mortality and morbidity. CMV …

AA Boudreault, H. Xie, RM Rakita, JD Scott, CL Davis, M. Boeckh, AP Limaye. Risk factors
for late‐onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney …

There is notable heterogeneity in the implementation of cytomegalovirus (CMV) prevention
practices among CMV‐seropositive (R+) kidney transplant (KT) recipients. In this …

Universal prophylaxis for cytomegalovirus (CMV) prevention is viable but, compared with a
preemptive strategy, leads to higher incidence of late-onset disease (LOD) associated with …

We assessed the impact of antiviral prophylaxis and preemptive therapy on the incidence
and outcomes of cytomegalovirus (CMV) disease in a nationwide prospective cohort of solid …

Cytomegalovirus infection (CMV) in solid organ transplant recipients is a major clinical
problem. The aim of this study was to evaluate the incidence of CMV infection and its …

Background. During the contemporary era of antiviral prophylaxis, the impact of delayed-
onset primary cytomegalovirus (CMV) disease on the outcome of kidney transplantation is …

Background. The incidence and impact of cytomegalovirus (CMV) disease that occurs
despite CMV prophylaxis among liver transplant recipients have been incompletely defined …